This is a phase 1, open-label, multicenter, randomized, 2-period, crossover study to evaluate the bioequivalence and food effect bioavailability of CC-486 (oral azacitidine) tablets in adult cancer subjects.
SparkCures ID | 638 |
---|---|
Trial Phase | Phase 1 |
Enrollment | 90 Patients |
Treatments |
|
Trial Sponsors |
|
NCT Identifier |
|
The following criteria is a partial list of reasons why patients may or may not be eligible to participate in this clinical trial. Further evaluation with a medical professional will be required to determine full eligibility.
The following criteria is provided for health care professionals.
Inclusion Criteria:
Exclusion Criteria:
Please visit the ClinicalTrials.gov page for historical site information.
View Centers